Evolus (NASDAQ: EOLS) reported Q4 EPS of ($0.11), $0.13 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $79 million versus the consensus estimate of $76.96 million.

GUIDANCE:

Evolus sees FY2025 revenue of $345-355 million, versus the consensus of $352 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.